Talvesta talotrexin: Phase I data

In a dose-escalation Phase I trial in 25 patients, 54 mg/m

Read the full 118 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE